Rizk, John G. http://orcid.org/0000-0002-5216-8695
Kalantar-Zadeh, Kamyar
Mehra, Mandeep R.
Lavie, Carl J.
Rizk, Youssef
Forthal, Donald N.
Article History
First Online: 3 September 2020
Declarations
:
: JGR, CJL, YR, DNF report no conflicts of interest to disclose relative to this research. KKZ has received honoraria and/or support from Abbott, Abbvie, ACI Clinical (Cara Therapeutics), Akebia, Alexion, Amgen, Ardelyx, ASN (American Society of Nephrology), Astra-Zeneca, Aveo, BBraun, Chugai, Cytokinetics, Daiichi, DaVita, Fresenius, Genentech, Haymarket Media, Hofstra Medical School, IFKF (International Federation of Kidney Foundations), ISH (International Society of Hemodialysis), International Society of Renal Nutrition and Metabolism (ISRNM), JSDT (Japanese Society of Dialysis Therapy), Hospira, Kabi, Keryx, Kissei, Novartis, OPKO, NIH (National Institutes of Health), NKF (National Kidney Foundations), Pfizer, Regulus, Relypsa, Resverlogix, Dr Schaer, Sandoz, Sanofi, Shire, VA (Veterans’ Affairs), Vifor, UpToDate, ZS-Pharma. MRM reports consulting relationships with Abbott, Medtronic, Janssen, Mesoblast, Portola, Bayer, NupulseCV, FineHeart, Leviticus, Roivant, Baim Institute for Clinical Research and Intrexon (Triple Gene).
: The authors received no financial support for the research, authorship, and/or publication of this article.
Free to read: This content has been made available to all.